Treatment of Malignant Melanoma With GPA-TriMAR-T Cell Therapy

Clinical trial NCT03649529 · UNKNOWN

Trial details

NCT number: NCT03649529
Sponsor: Timmune Biotech Inc.
Status: UNKNOWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

Malignant Melanoma

Start date: 2018-09-27
Primary completion: 2021-09-15
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.